TY - JOUR
T1 - Imaging the ADHD brain
T2 - disorder-specificity, medication effects and clinical translation
AU - Rubia, Katya
AU - Alegria, Analucia
AU - Brinson, Helen
PY - 2014/5
Y1 - 2014/5
N2 - A plethora of magnetic resonance imaging studies have shown that ADHD is characterized by multiple functional and structural neural network abnormalities beyond the classical fronto-striatal model, including fronto-parieto-temporal, fronto-cerebellar and even fronto-limbic networks. There is evidence for a maturational delay in brain structure development which likely extends to brain function and structural and functional connectivity, but this needs corroboration by longitudinal imaging studies. Dysfunction of the ventrolateral prefrontal cortex seems to be more pronounced relative to other pediatric disorders and is also the most consistent target of acute psychostimulant medication. Future studies are likely to focus on using neuroimaging for clinical translation such as for individual diagnostic and prognostic classification and as a neurotherapy to reverse brain function abnormalities.
AB - A plethora of magnetic resonance imaging studies have shown that ADHD is characterized by multiple functional and structural neural network abnormalities beyond the classical fronto-striatal model, including fronto-parieto-temporal, fronto-cerebellar and even fronto-limbic networks. There is evidence for a maturational delay in brain structure development which likely extends to brain function and structural and functional connectivity, but this needs corroboration by longitudinal imaging studies. Dysfunction of the ventrolateral prefrontal cortex seems to be more pronounced relative to other pediatric disorders and is also the most consistent target of acute psychostimulant medication. Future studies are likely to focus on using neuroimaging for clinical translation such as for individual diagnostic and prognostic classification and as a neurotherapy to reverse brain function abnormalities.
U2 - 10.1586/14737175.2014.907526
DO - 10.1586/14737175.2014.907526
M3 - Article
C2 - 24738703
SN - 1473-7175
VL - 14
SP - 519
EP - 538
JO - Expert Review of Neurotherapeutics
JF - Expert Review of Neurotherapeutics
IS - 5
ER -